EFDAMROFUSP ALFA
UNII N88X8JV8VP

Substance Identification & Data

This profile provides standardized clinical and technical data for Efdamrofusp Alfa, uniquely identified by the FDA Unique Ingredient Identifier (UNII) N88X8JV8VP.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2375661-82-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
N88X8JV8VP
CAS Registry Number
2375661-82-6
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
EFDAMROFUSP ALFA
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
11671
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Efdamrofusp Alfa. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

EFDAMROFUSP ALFA

Common Names & Synonyms

104-205-VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 1 (HUMAN) FUSION PROTEIN WITH 207-308-VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (HUMAN) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (HUMAN .GAMMA.1-CHAIN C REGION C-TERMINAL FRAGMENT) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGGG) FUSION PROTEIN WITH 1-192-TYPE I COMPLEMENT RECEPTOR (29-LYSINE,37-TYROSINE,79-ASPARTIC ACID,109-ASPARAGINE) (HUMAN), DIMER
EFDAMROFUSP ALFA [INN]